Revenue growth will be driven by macro environment improvements and recovery from past actions. Read more to see why JD stock ...

Dow's shares have gained 6% over the past year, lagging behind the S&P 500, due to ongoing weakness in China. Check out what ...

A surge in Chinese stocks last month helped Asia hedge funds pull ahead of global peers for the first three quarters, after ...

Shares in the Boston-based biotech creator, which had a standout success in forming Karuna Therapeutics, trade around cash levels — a "huge value disconnect" its leaders are trying to bridge.

The Q3 earnings season is now in full swing, and looking at the financial results so far, the news is pretty good. David ...

Latin America is anxiously counting the days to Nov. 5, when U.S. voters will choose between relative continuity under Vice ...